Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study

NCT01836692 is registered in ClinicalTrials.gov with Prof Corinne Faivre-Finn as lead sponsor.

NCT NCT01836692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01836692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
Lead sponsor
Prof Corinne Faivre-Finn
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
June 30, 2018
Enrollment
38 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer